GenScript Launches TurboCHO Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class

New kit offers researchers and development teams a meaningful advance in expression speed and output

BOSTON, May 12, 2026 /PRNewswire/ -- GenScript Biotech Corporation announced the launch of TurboCHO Protein Expression Kit, a next-generation antibody expression reagent designed to set a new benchmark for speed, performance, output and ease-of-use. One of the company's largest global product launches to date, this kit targets the fast-growing expression reagent market, driven by high-throughput and AI-enabled research.

Producing research-grade antibodies and proteins is a foundational step in drug discovery and biologics development. The new kit brings GenScript's proven protein-expression technology directly to the bench in a ready-to-use format, enabling labs of any size to generate high‑quality protein in as little as five business days. As a result, researchers can access reliable data sooner and make earlier, more confident decisions.

"TurboCHO Protein Expression Kit delivers outstanding performance and unmatched value, putting powerful innovation within reach of every lab working to advance science," said GenScript's Rotating CEO Sherry Shao. "By providing a launchpad to market, this kit helps bring new medicines to patients' faster, when time matters most."

The product debuted yesterday at the opening of the PEGS Summit in Boston, but attendees will have opportunities throughout the week to learn more and engage with the GenScript team. The Protein Expression Kit is available in two configurations:

• Pro: Delivers high-yield protein expression in as little as 5 business days, designed for easy integration into existing workflows.
• Prime (Licensed): Enhanced performance for teams seeking maximum speed, with results as early as Day 3 and even higher yields.

Early Feedback Supports Real-World Impact

Early adopters in the beta program have reported performance that is "best in class" for speed and value, demonstrating its real-world impact.

_________________________________________________________________________________

Performance Snapshot: How the Kit Compares

• Redefines expression speed, providing Day 5 yields (or Day 3 for Prime) comparable to competitor Day 10 results, substantially shortening timelines and accelerating decision-making
• Delivers higher yields with lower reagent input, improving overall cost efficiency and throughput
• Produces up to three-fold higher yield (or 5-fold for Prime) after Protein A purification versus other market solutions
• Features a proprietary high‑performing cell line and optimized transfection system

_________________________________________________________________________________

Schreibe Deinen Kommentar